A group of 15 researchers, made up of biologists, biochemists, technicians and doctors from the Institute of Translational Medicine Research (CONICET-Universidad Austral) and the César Milstein Institute of Science and Technology (CONICET-Cassará Foundation), designed a new drug to treat chronic pain of neuropathic and inflammatory origin.